InvestorsHub Logo
Followers 88
Posts 1175
Boards Moderated 0
Alias Born 09/10/2017

Re: Evaluate post# 363096

Thursday, 03/18/2021 2:57:35 AM

Thursday, March 18, 2021 2:57:35 AM

Post# of 708459
Good points Evaluate. It may be difficult for some people to appreciate just how much progress has been made at Sawston because several posters have been suggesting that they were already certified, so this update was a bit of a reality check. What’s even more impressive to me is just how inexpensively this has been accomplished. Recall this Q & A from the Charles River earnings call:

Tycho Peterson
Hey. Thanks. A couple of follow-ups here. Jim starting with Cognate. I want to go back to John Kreger's question on CapEx. If we look at some of the other CDMOs whether it's Catalent with Paragon and MaSTherCell or Thermo with Brammer. The cost of building out facilities here are not insignificant in the kind of $150 million to $250 million range for commercial cell and gene therapy facilities.

https://seekingalpha.com/article/4406754-charles-river-laboratories-international-inc-crl-ceo-jim-foster-on-q4-2020-results-earnings

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News